0.00Open0.00Pre Close0 Volume0 Open Interest62.00Strike Price0.00Turnover328.01%IV-20.61%PremiumNov 29, 2024Expiry Date16.10Intrinsic Value100Multiplier1DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9581Delta0.0082Gamma4.79Leverage Ratio-0.7131Theta0.0011Rho4.59Eff Leverage0.0030Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
Great products sells itself, ask novo disk and how they sell ozempic
No comment yet